Rickard E Malmström
Affiliation: Karolinska Institutet
- Personalizing health care: feasibility and future implicationsBrian Godman
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86, Stockholm, Sweden
BMC Med 11:179. 2013..Overall, personalized medicine has the potential to revolutionize care. However, current challenges and concerns need to be addressed to enhance its uptake and funding to benefit patients. ..
- No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose toleranceRickard E Malmström
Department of Medicine Solna, Clinical Pharmacology Unit, Karolinska University Hospital Solna, SE 171 76 Stockholm, Sweden
Thromb Haemost 101:157-64. 2009....
- Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatmentRickard E Malmström
Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden
J Intern Med 266:457-66. 2009..Possible interactions between clopidogrel and atorvastatin, simvastatin or rosuvastatin (a 'non-CYP3A4' metabolized statin) were investigated in a randomized prospective study using sensitive and specific ex vivo platelet function tests...
- Endothelin attenuates endothelium-dependent platelet inhibition in manR E Malmstrom
Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Acta Physiol (Oxf) 198:441-8. 2010..Experiments were designed to investigate the effect of ET-1 on endothelium-dependent vasodilatation and attenuation of platelet activation...